SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gan & Lee Says GRADUAL-3 Study Meets Primary Endpoint

Gan & Lee Pharmaceuticals reported positive results for once-monthly bofanglutide maintenance therapy in weight control and maintenance over 24 weeks.

Related stories